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Supplementary Tables
The following tables present P values from post-hoc pairwise multiple comparisons tests by using the Tukey, Bonferroni, Fisher's least-significant-difference, and Scheffé methods for the listed parameters. The most conservative method was selected and used for difference evaluation. 
MI with PBS administration, and FGF21
-/-MI with FGF21 administration, respectively. Table 5 . Left ventricular (LV) dp/dt and -dp/dt (absolute value) at 1, 5, 10, and 30 days. Table 5 .1. Multiple comparisons in LV dp/dt in reference to times. The P value from the global ANOVA test (two-way) is > 0.5. Table 5 .2. Multiple comparisons in LV dp/dt in reference to treatments. The P value from the global ANOVA test (two-way) is < 0.0001. 
P values
MI with PBS administration, and FGF21
-/-MI with FGF21 administration, respectively. Table 5 .3 Multiple comparisons in LV -dp/dt in reference to times. The P value from the global ANOVA test (two-way) is > 0.5. Table 5 .4. Multiple comparisons in LV -dp/dt in reference to treatments. The P value from the global ANOVA test (two-way) is < 0.0001. The letters a, b, c, d, and e represent control, FGFR1, -Klotho, PI3K p110, and Akt1 siRNA treatments, respectively.
P values
